Contents
  1. New hope for dogs with herniated discs: Chondroitinase injections for dogs – what you need to know now
  2. Chondroitinase injection in dogs: background, benefits, procedure and limitations
  3. Frequently asked questions (FAQ)
  4. Detailed summary: Chondroitinase injection for dogs
  5. Sources (selection, in English)

New hope for herniated discs: Chondroitinase injection for dogs – what you need to know now

Chondroitinase injection for dogsBackground, benefits, process and limitations

As a veterinarian who sees dogs with acute back problems daily, I am pleased about a development that offers many small dogs with intervertebral disc herniation a real additional option: the Chondroitinase injection for dogs. In this procedure, an enzyme (chondroitinase ABC) is injected minimally invasively directly into affected intervertebral discs. The aim is to liquefy the central portion of the disc, relieve pressure on the spinal cord, and thus alleviate paralysis or severe pain more quickly and with less strain – in selected cases as an alternative to surgery. Recent reports from a British university clinic describe how, since the beginning of 2025, several dozen treated dogs were able to walk again after just a few days; the method is currently offered there as a standard procedure at the only facility in the United Kingdom. University of Cambridge

Chondroitinase injection in dogs
Chondroitinase injection for dogs 2

What is behind IVDD – and why is it relevant for the Chondroitinase injection for dogs?

The most common cause of severe spinal cord problems in small dogs is... Intervertebral disc disease (IVDD). A characteristic feature is that degenerated disc material protrudes into the spinal canal and compresses the spinal cord. Clinically, we see a range of symptoms from "just" back pain to ataxia and even dogs suddenly unable to walk, with urinary and fecal incontinence. Pathophysiologically, early degeneration and calcification of the nucleus pulposus predominate in chondrodystrophic breeds (e.g., Dachshunds), which promotes the acute "ejection" of disc material. Understanding this mechanism explains why the enzymatic "cleanup" of the nucleus pulposus—that is, the Chondroitinase injection for dogs – which seems logical in precisely these cases. MDPI+2Today's Veterinary Practice+2

Why does the Chondroitinase injection for dogs as a breakthrough?

In a multicenter clinical trial, small dogs with acute paraparesis or paraplegia due to a herniated disc were treated with intradiscal chondroitinase injections. The published results show that in suitable patients (especially those with preserved proprioception), walking recovery rates were comparable to those achieved with current standard procedures – but with less invasiveness. A US university involved in the development of the treatment stated in its press release that the efficacy in these cases approached that of surgical outcomes. AVMA Journals+1

At the same time, the Queen's Veterinary School Hospital (QVSH) in Cambridge reports that the Chondroitinase injection for dogs It is regularly available there, following recognition as a Routine Veterinary Practice (RVP) by the British Royal College of Veterinary Surgeons. For some patients, this offers a more cost-effective, less invasive option – often allowing them to go home on the same or following day. hospital.vet.cam.ac.uk+1

For which dogs is the Chondroitinase injection for dogs Is this an option?

Not every dog with IVDD benefits equally. The following factors are crucial:

  • Clinical statusIdeally, there is acute paralysis/weakness, but the perception of deep pain is still present. In this group, the results of the Chondroitinase injection for dogs described in a particularly convincing manner. VMBS
  • breed and sizeMany affected breeds are small, chondrodystrophic breeds such as Dachshunds. IVDD is particularly common in Dachshunds – British sources emphasize a very high prevalence; the new technique was developed, among other things, using these patients. University of Cambridge
  • Time factorThe faster the spinal cord is relieved of pressure, the better the prognosis – regardless of the procedure. This argues for rapid diagnosis and treatment. (For general IVDD prognostic factors, see, for example, the Merck Veterinary Manual.) Merck Veterinary Manual

How does it work? Chondroitinase injection for dogs away?

After stabilization and imaging (usually CT/MRI plus fluoroscopic guidance), the intervertebral discs are punctured. Under sedation, the enzyme is precisely injected into the target discs using fine needles; in many cases, the dog can go home on the same day or the following day. Aftercare is similar to conservative therapy (pain management, strict leash rest, controlled muscle building) with follow-up appointments by phone or in the office. hospital.vet.cam.ac.uk+1

What are the chances of success?

In Cambridge, two dozen dogs have been treated since the beginning of 2025 – according to the clinic report, all regained mobility within a few days. At the same time, the scientific publication/communication from the study with 54 dogs shows that recovery rates from walking can be comparable to surgical options if case selection is appropriate. Important: These figures come from specialized centers; individual outcomes may vary. University of Cambridge+1

Risks and limitations of Chondroitinase injection for dogs

No procedure is without risks. Potential side effects have been described, including those caused by the puncture itself (e.g., bleeding, infections, nerve damage – rare), by the enzyme (adverse tissue reactions), or by the anesthesia/sedation. Furthermore, without deep pain, the prognosis for IVDD is generally much more guarded – the likelihood of surgical success is also limited in such cases; the same applies analogously to... Chondroitinase injection in dogs. The Phase 1 study explicitly investigated safety and walking recovery; the data is growing, but remains recent – personal consultation with clinical examination and imaging is essential. AVMA Journals+1

What does recognition as a "Routine Veterinary Practice" mean?

The classification as a "Routine Veterinary Practice (RVP)" by the RCVS means that the Chondroitinase injection in dogs In the UK, treatment may be offered outside of strict study protocols, provided that professional diligence and indication are adhered to. This facilitates access but still requires thorough patient education, documentation, and follow-up care. rcvs.org.uk

Availability, costs, perspectives

Currently the Chondroitinase injection in dogs Offered in the UK at the QVSH; specialist articles/industry reports confirm the still limited availability. At the same time, US centers are significantly involved in research and implementation. For German owners, referral to a European reference center or participation in ongoing studies is currently the most pragmatic approach; international expansion to further locations is expected as experience and protocols mature. hospital.vet.cam.ac.uk+2DVM360+2

Classification alongside conservative therapy and surgery

Conservative management (pain medication, anti-inflammatories, rest, physiotherapy) remains appropriate for mild cases. For dogs unable to walk, surgery has often been the first choice, as it mechanically removes the extruded material. Chondroitinase injection in dogs It closes the gap: It enzymatically targets the nucleus pulposus, can reduce pressure, and enable functional recovery – without bone abrasion or opening the spinal canal. However, it does not replace emergency surgery in all situations (e.g., in cases of severe complications). The decision is individualized and depends on the neurological status, the available time, imaging findings, clinical expertise, and the owner's wishes. andersonmoores.com+1

Frequently asked questions (FAQ)

1) Is the Chondroitinase injection for dogs Is it truly an alternative to surgery – or just an „intermediate step“?

From a veterinary perspective, it is both: a genuine alternative for suitable Patients and, at the same time, a missing link between conservative management and classic decompression surgery. The available evidence shows that the Chondroitinase injection in dogs In small dogs with acute paraparesis/paraplegia and preserved deep pain perception, walking recovery rates can be achieved that are comparable to established procedures – but with less invasiveness, shorter hospital stays and potentially lower costs.

This is particularly important when surgery is not possible for medical reasons (accompanying illnesses, high anesthetic risk) or financial reasons. At the same time, surgery remains superior in some situations – for example, in cases of massive extrusions with serious complications, in cases of impaired deep pain perception, or when imaging shows that exposed, "hard" material is pressing directly on the spinal cord and should be mechanically removed. Therefore, in our practice, we always emphasize: diagnosis first (neurological examination, imaging), then appropriate therapy – and then can the Chondroitinase injection in dogs a very useful part of the spectrum. AVMA Journals+2VMBS+2

2) Which dogs are suitable for the Chondroitinase injection for dogs Who is in question – and who is less likely to be in question?

Candidates are typically small, chondrodystrophic dogs (e.g., Dachshund, French Bulldog, Shih Tzu, Beagle) with acute spinal cord compression due to intervertebral disc extrusion in the thoracic-lumbar region, who are unable to walk., but still show deep pain. Very good recovery rates have been documented in studies and clinical reports for this group. The following is not ideal: Chondroitinase injection in dogs In cases of chronic conditions without an acute component, in patients with multiple, heavily calcified protrusions without a focal primary cause, in cases of severe cervical compression with respiratory risk, in cases of absent deep pain perception, and in cases of contraindications to sedation/anesthesia, imaging is always crucial: meaningful planning is impossible without CT/MRI and fluoroscopy. And even though dachshunds are particularly frequently affected (high lifetime prevalence; some sources cite around 20 % and more), IVDD can affect virtually any breed. Individual assessment and patient education by a neurologist remain paramount. University of Cambridge+2BSAVA+2

3) What does the procedure and aftercare look like? Chondroitinase injection for dogs Off – when can my dog run again?

Once the diagnosis is confirmed, your dog will be sedated. Under X-ray guidance, fine needles are precisely inserted into the affected intervertebral discs, and the enzyme is slowly injected. The procedure is short, and the hospital stay is often only a few hours to a day. Many clinics discharge dogs with a clear home care program: strict rest (leash/crate), consistent pain management, thrombosis and pressure ulcer prophylaxis for dogs unable to walk, early passive range-of-motion exercises, and later, targeted physiotherapy with controlled muscle building. In published case reports, some successful cases were able to walk again within a few days – but this varies: some dogs need weeks, depending on their initial condition and the spinal cord injury. Regular follow-up appointments (phone, email, and, if necessary, in-person visits) are important to monitor progress, bladder function, and any potential side effects. Adhere closely to the written aftercare plan – it is just as important as the actual surgery. Chondroitinase injection in dogs. hospital.vet.cam.ac.uk+2hospital.vet.cam.ac.uk+2

4) What risks does the Chondroitinase injection in dogs – and how safe is the procedure?

Safety was systematically investigated in a Phase 1 study, which focused on side effects and walking recovery. Overall, the Chondroitinase injection in dogs When performed carefully, it is generally well tolerated. Theoretical risks include injury-related bleeding, infection, accidental nerve irritation, enzyme-related reactions, and complications from sedation/anesthesia. In addition, there are disease-specific risks: In IVDD, secondary spinal cord degeneration can occur despite therapy; some cases still require subsequent surgery if the response is insufficient. Compared to open decompression surgery, incisions, bone windows, and manipulative procedures on the spinal cord are eliminated – this reduces certain surgical risks, but does not mean "zero risk." The experienced neurologist will discuss with you, based on the images and your neurological status, whether the Chondroitinase injection in dogs in your case it offers a good benefit-risk ratio. AVMA Journals

5) Where is the Chondroitinase injection in dogs Available – and what does the RCVS rating mean for me as the owner?

Currently, there is a university center in Great Britain that... Chondroitinase injection in dogs The treatment is regularly offered; reports in the specialist press confirm its exclusive availability in the UK. Simultaneously, US universities are publishing their data and some are even offering study places. For you, the British RCVS classification as "Routine Veterinary Practice" means that the method – with correct indication and informed consent – may be used outside of purely clinical trials. This simplifies scheduling and planning; however, an individual benefit-risk assessment remains mandatory. If you are considering treatment, obtain referral documents (previous history, neurology report, imaging data), inquire about the team's experience, aftercare plan, realistic goals, complication management, and total costs. A well-founded second opinion is legitimate – especially when deciding between surgery, conservative treatment, and other options. Chondroitinase injection in dogs. hospital.vet.cam.ac.uk+2DVM360+2

Detailed summary: Chondroitinase injection for dogs

The Chondroitinase injection in dogs is a minimally invasive treatment option for intervertebral disc disease (IVDD) that targets the source of the problem: the nucleus of the disc. By liquefying the nucleus, the enzyme relieves pressure on the spinal cord, aiming to improve neurological deficits and get the dog back on its feet more quickly. For many owners, the Chondroitinase injection for dogs Therefore, it is a welcome alternative when open surgery is not possible or desired. International reports focus on the fact that Chondroitinase injection for dogs In selected cases, it delivers comparable walking recovery rates to surgical decompression, but with a shorter hospital stay.

Small dogs with chondrodystrophic conditions particularly benefit: IVDD is especially common in dachshunds, and it is precisely there that the Chondroitinase injection in dogs their potential. Case selection is crucial: If acute paralysis is present, but deep pain perception is still intact, the Chondroitinase injection for dogs They offer very good chances. Without deep pain, however, the prognosis becomes significantly more guarded, regardless of the method. In practice, this means: First, a thorough diagnosis, then a targeted decision for or against treatment. Chondroitinase injection in dogs.

The procedure is structured: After imaging and stabilization, the precise injection takes place under sedation and X-ray guidance – the Chondroitinase injection for dogs This makes it predictable and standardizable. Follow-up care begins immediately afterwards: rest, controlled mobilization, pain management, and – if possible – early physiotherapy. The success of the Chondroitinase injection for dogs Success hinges on consistent follow-up care; it is an integral part of the overall concept. Many clinics report that dogs make rapid progress, some even within a few days – nevertheless, the Chondroitinase injection for dogs Not a "miracle cure", but an evidence-based option with realistic, but not guaranteed, goals.

Security aspects must be taken seriously, but are addressed through structured protocols. Chondroitinase injection in dogs It avoids incisions and bone windows, thus eliminating typical surgical risks. However, risks associated with the puncture and sedation remain. Therefore, the Chondroitinase injection in dogs into the hands of experienced teams with image guidance and emergency management. Discussions about side effects and alternatives are part of every informed consent process.

The supply situation is developing rapidly. Currently, the Chondroitinase injection for dogs It is regularly available at a British university hospital, supported by studies and teaching/press reports. This creates planning certainty for owners who want a Chondroitinase injection for dogs They are considering this – even across borders. At the same time, international groups are working to refine indications, standardize protocols, and gather long-term data on Chondroitinase injection for dogs to collect data. It is expected that more centers will follow as experience and guidelines grow. Until then, I advise affected families individually: Not every dog needs surgery, not every dog benefits from conservative therapy – and not every dog is a candidate for the Chondroitinase injection for dogs.

What does this mean for you in practical terms? If your dog suddenly cries out, refuses to jump, walks unsteadily, or even loses weight on its hind legs, it's an emergency. Don't hesitate and seek veterinary help immediately. The earlier the diagnosis, the greater the chance that – if appropriate – the Chondroitinase injection in dogs is even a possibility. Please bring any previous findings, describe the exact course of the illness, and pay attention to bladder/bowel control. Together, we will fit the puzzle pieces (clinical presentation, imaging, time frame) so that the Chondroitinase injection in dogs gets a fair chance – or we explain why surgery or conservative management are wiser.

The bottom line is... Chondroitinase injection for dogs Currently one of the most exciting developments in small animal neurology. It expands our range of options, gives owners more choices, and – when correctly indicated – can lead to surprisingly rapid functional improvements. Through the combination of minimal invasiveness, structured execution, and growing data, the Chondroitinase injection in dogs For many small dogs with IVDD, this is a serious component of modern care. As your Veterinarian I will accompany you in the decision as to whether the Chondroitinase injection for dogs in your In this specific case, it's the right step – with clear information, an honest prognosis, and an aftercare plan that will safely lead your dog back to life. Unfortunately, since this treatment isn't yet available in Germany, we'll have to wait a little longer!

Sources (selection, in English)

  • University of Cambridge – News on the new enzyme injection, availability and case numbers. University of Cambridge
  • Queen's Veterinary School Hospital (QVSH) – Treatment page, recognition as an RVP, procedure, aftercare; study information. hospital.vet.cam.ac.uk+1
  • Texas A&M University – Press release on clinical trial and efficacy in dogs with preserved deep pain perception. VMBS
  • JAVMA – Phase 1 publication on safety and gait recovery after intradiscal chondroitinase (chemonucleolysis). AVMA Journals
  • DVM360 – Industry report on current availability in the UK. DVM360
  • RCVS – Guidance on the distinction between Routine Veterinary Practice and Research. rcvs.org.uk
  • Merck Veterinary Manual / Reviews – Background on IVDD, Clinical Aspects and Pathophysiology. Merck Veterinary Manual+1

Related posts:

  1. Slipped disc in dogs
  2. Dementia in dogs
  3. Ataxia in dogs
  4. DISHAA - Tool - immediately
Scroll to Top